ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 55 filers reported holding ADICET BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,224,618 | -35.4% | 893,882 | +14.6% | 0.00% | 0.0% |
| Q2 2023 | $1,894,620 | +101761.3% | 779,679 | +141.5% | 0.00% | -50.0% |
| Q1 2023 | $1,860 | +7.4% | 322,876 | +66.7% | 0.00% | – |
| Q4 2022 | $1,732 | -99.9% | 193,687 | +84.5% | 0.00% | -100.0% |
| Q3 2022 | $1,493,000 | -42.8% | 105,000 | -41.2% | 0.00% | 0.0% |
| Q2 2022 | $2,609,000 | +161.2% | 178,666 | +257.3% | 0.00% | 0.0% |
| Q1 2022 | $999,000 | +461.2% | 50,000 | +119.8% | 0.00% | – |
| Q3 2021 | $178,000 | -81.9% | 22,747 | -76.1% | 0.00% | -100.0% |
| Q2 2021 | $981,000 | -58.3% | 95,352 | -47.0% | 0.00% | -50.0% |
| Q1 2021 | $2,355,000 | +659.7% | 180,041 | +715.5% | 0.00% | – |
| Q4 2020 | $310,000 | – | 22,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |